GO:0005901; C:caveola; IDA:RGD
GO:0005794; C:Golgi apparatus; IDA:RGD
GO:0030027; C:lamellipodium; IDA:RGD
GO:0005634; C:nucleus; IDA:RGD
GO:0005886; C:plasma membrane; IDA:RGD
GO:0042383; C:sarcolemma; IDA:RGD
GO:0070290; F:N-acylphosphatidylethanolamine-specific phospholipase D activity; IEA:UniProtKB-EC
GO:0035091; F:phosphatidylinositol binding; IEA:InterPro
GO:0004630; F:phospholipase D activity; IDA:RGD
GO:0005080; F:protein kinase C binding; IPI:RGD
GO:0031175; P:neuron projection development; IMP:RGD
GO:0009395; P:phospholipid catabolic process; IMP:RGD
GO:0045785; P:positive regulation of cell adhesion; IMP:RGD
GO:0030335; P:positive regulation of cell migration; IMP:RGD
GO:0043306; P:positive regulation of mast cell degranulation; IMP:RGD
GO:0014068; P:positive regulation of phosphatidylinositol 3-kinase signaling; IMP:RGD
GO:0048260; P:positive regulation of receptor-mediated endocytosis; IMP:RGD
GO:0042542; P:response to hydrogen peroxide; IMP:RGD
GO:0001666; P:response to hypoxia; IDA:RGD
GO:0014070; P:response to organic cyclic compound; IDA:RGD
GO:0043434; P:response to peptide hormone; IMP:RGD